Most health insurance plans can cover weight loss medications, but many don’t, and the ones that do typically require you to meet specific clinical criteria before they’ll approve a prescription. Only about 19% of large employer-sponsored plans currently include coverage for GLP-1 weight loss drugs like Wegovy and Zepbound, according to KFF survey data. Whether you’re covered depends on your plan type, your employer’s choices, and your medical history.
Why Coverage Varies So Much
There is no federal law requiring private insurers to cover weight loss medications. Each insurer and its medical leadership decide independently whether to include these drugs on their formulary (the list of medications a plan will pay for). On top of that, employers who sponsor health plans can choose to exclude weight loss drugs entirely, and many do. The result is a patchwork: two people with plans from the same insurance company can have completely different coverage depending on their employer’s choices.
This means you cannot assume coverage based on your insurer’s name alone. The most reliable step is to call the number on the back of your insurance card and ask whether your specific plan covers anti-obesity medications. Ask for the drug by name, since a plan might cover one GLP-1 medication but not another.
Employer-Sponsored Plans
Among large firms (200 or more workers) that offer health benefits, only about 19% cover GLP-1 medications when used primarily for weight loss. That leaves roughly 4 out of 5 large employer plans without this coverage. Smaller employers are even less likely to include it, largely because of cost concerns.
Some employers that do offer coverage add extra requirements. About a third of firms covering GLP-1 drugs for weight loss require employees to participate in a lifestyle or clinical support program alongside the medication. Others use step therapy, meaning you must try a less expensive treatment first and show it didn’t work before the plan will approve a costlier drug. A few employers restrict coverage to people who have a specific diagnosis like type 2 diabetes, meaning the same drug might be covered for blood sugar management but denied for weight loss alone.
What Insurers Typically Require
Even when a plan does cover weight loss medication, you’ll almost certainly need prior authorization. That means your doctor submits documentation to the insurer proving you meet the plan’s clinical criteria before the pharmacy can fill the prescription. Common requirements include:
- BMI of 30 or higher, which qualifies as clinical obesity. At this threshold, many plans will consider coverage with no additional conditions beyond the other requirements listed here.
- BMI of 27 to 29.9 plus obesity-related health conditions. If your BMI falls in this range, insurers often require that you’re being treated for at least two related conditions, such as high cholesterol, high blood pressure, type 2 diabetes, sleep apnea, or cardiovascular disease.
- Documented participation in a weight loss program. Many plans require proof that you’ve followed a structured weight loss effort, such as nutritional counseling, a calorie-restricted diet, or an exercise regimen, for at least six months before they’ll approve medication.
- No pregnancy or nursing, and no history of eating disorders like anorexia, bulimia, or binge eating disorder.
Your insurer may not cover these drugs if your only qualifying factor is a high BMI. Some plans require you to have an obesity-related medical problem on top of the weight itself. This is one of the most common reasons for denial, so it’s worth understanding your plan’s specific threshold before your doctor submits the authorization request.
If you’re approved and the medication is working, expect periodic check-ins. Some plans will not renew authorization if your BMI drops below 24, on the reasoning that the clinical need for the drug has been resolved.
Medicare Coverage
Medicare Part D has historically excluded coverage for weight loss drugs. That is beginning to change. CMS (the agency that runs Medicare) has announced a demonstration program called the Medicare GLP-1 Bridge, which will provide eligible Part D beneficiaries access to specific GLP-1 drugs for weight loss, including Wegovy, Zepbound, and Foundayo. The program runs from July 1, 2026, through December 31, 2027.
If you’re on Medicare and interested in weight loss medication, check with your Part D plan about eligibility for this demonstration. Keep in mind this is a temporary program, not a permanent change to Medicare’s drug benefit. Medicare does currently cover GLP-1 medications when prescribed for type 2 diabetes (brand names like Ozempic or Mounjaro), since the diabetes indication has long been a covered use.
Medicaid Coverage
Medicaid coverage for weight loss drugs varies by state. Some state Medicaid programs cover anti-obesity medications with prior authorization, while others exclude them. The clinical criteria in states that do provide coverage tend to mirror what private insurers require: a minimum BMI, documented comorbidities for lower BMI ranges, and participation in a lifestyle modification program. Contact your state’s Medicaid office or managed care plan directly to find out what’s available.
What to Do If You’re Denied
A denial isn’t necessarily the final answer. You have the right to appeal, and the process typically works in stages. First, ask your insurer for the specific reason for the denial in writing. Then work with your doctor to submit an internal appeal, which usually involves a letter of medical necessity explaining why the medication is appropriate for your situation, along with supporting documentation like lab results, your weight history, and records of prior weight loss attempts.
If the internal appeal fails, most plans allow an external review by an independent third party. Your insurer is required to tell you about your appeal rights in the denial letter, including deadlines. These deadlines matter: missing them can forfeit your right to appeal.
Paying Without Insurance Coverage
If your plan doesn’t cover weight loss medication, or while you’re waiting on an appeal, there are ways to reduce the cost. Novo Nordisk, the maker of Wegovy, offers a savings program for both commercially insured patients and those who are uninsured or self-paying. You can enroll through NovoCare online or by texting SAVE to 83757. Eli Lilly offers a similar program for Zepbound.
These manufacturer programs can significantly reduce out-of-pocket costs, though they typically don’t apply if you’re on Medicare, Medicaid, or other government-funded insurance. The savings amounts and eligibility rules change periodically, so check the manufacturer’s website for current terms. Some patients also find lower prices by comparing costs across pharmacies, including specialty and mail-order options, since retail pricing for these drugs can vary widely.